Rho kinase contributes to androgen amplification of renal vasoconstrictor responses in the spontaneously hypertensive rat

Journal of Cardiovascular Pharmacology

Volumn 48, Issue 3, 2006, Pages 103-109

  Song, Jin ^a   Martin, Douglas S ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Androgens; Hypertension; Renal vasoconstriction; Rho kinase

Indexed keywords

ANDROGEN; FASUDIL; NORADRENALIN; RHO KINASE; RHO KINASE INHIBITOR; TESTOSTERONE; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CASTRATION; CONTROLLED STUDY; HEART RATE; HYPERTENSION; ISOLATED KIDNEY; KIDNEY PERFUSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASOCONSTRICTION;

ANDROGENS; ANIMALS; HYPERTENSION; KIDNEY; MALE; POTASSIUM CHLORIDE; RATS; RATS, INBRED SHR; RHO GTP-BINDING PROTEINS; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 33749836644     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000245403.45406.d8     Document Type: Article

References (59)

1. Dubey RK, Oparil S, Imthurn B, et al. Sex hormones and hypertension. Cardiovasc Res. 2002;53:688-708.
2. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001;37:1199-1208.
3. Reckelhoff JF. Sex steroids, cardiovascular disease and hypertension. Hypertension. 2005;45:170-174.
4. Ganten U, Schroeder C, Witt M, et al. Sexual dimorphism of blood pressure in spontaneously hypertensive rats: effect of antiandrogen treatment. J Hypertens. 1989;7:721-726.
5. Ashton N, Balment RJ. Sexual dimorphism in renal function and hormonal status of New Zealand genetically hypertensive rats. Acta Endocrinol. 1991;124:91-97.
6. Jenkins C, Salisbury R, Ely D. Castration lowers and testosterone restores blood pressure in several rat strains on high sodium diet. Clin Exp Hypertens. 1994;16:611-625.
7. Grisk O, Rettig R. Renal transplantation studies in genetic hypertension. News Physiol Sci. 2001;16:262-265.
8. Rettig R, Bandelow N, Patschan O, et al. The importance of the kidney in primary hypertension: insights from cross-transplantation. J Hum Hypertens. 1996;10:641-644.
9. Hall JE, Mizelle HL, Hildebrandt DA, et al. Abnormal pressure natriuresis: a cause or consequence of hypertension. Hypertension. 1990;15:547-559.
10. Reckelhoff JF, Zhang J, Granger JP. Testosterone exacerbates hypertension and reduces pressure natriuresis in male spontaneously hypertensive rats. Hypertension. 1998;31:435-439.
11. Nagawa K, Marji JS, Schwartzman ML, et al. Androgen mediated induction of kidney arachidonate hydroxylases is associated with the development of hypertension. Am J Physiol. 2003;284:R1055-R1062.
12. Gebremedhin D, Ma YH, Imig JD, et al. Role of cytochrome P-450 in elevating renal vascular tone in spontaneously hypertensive rats. J Vasc Res. 1993;30:53-60.
13. Imig J, Falck J, Gebremedhin D, et al. Elevated renovascular tone in young spontaneously hypertensive rats: role of cytochrome P-450. Hypertension. 1993;22:357-364.
14. Snackenburg C, Welch W, Wilcox C. Normalization of blood pressure and renal vascular resistance in SHR with a membrane permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension. 1998;32:59-64.
15. Trippodo NC, Frolich ED. Similarities of genetic (spontaneous) hypertension: man and rat. Circ Res. 1981;48:309-315.
16. Uyehara CF, Gellai M. Impairment of renal function precedes establishment of hypertension in spontaneously hypertensive rats. Am J Physiol. 1993;265:R943-950.
17. Kost CK, Herzer WA, Li P, et al. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats. J Pharmacol Exp Ther. 1994;269:82-88.
18. Smeda J, Lee R, Forrest J. Structural and reactivity alterations of the renal vasculature of spontaneously hypertensive rats prior to and during established hypertension. Circ Res. 1988;63:518-533.
19. Feng J, Arendshorst W. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors. Am J Physiol. 1996;27:F304-F313.
20. Song J, Kost CK Jr, Martin DS. Androgens augment renal vascular responses to ANG II in New Zealand genetically hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1608-1615.
21. Cavarape A, Bauer J, Bartoli E, et al. Effects of angiotensin II, arginine vasopressin and tromboxane A2 in renal vascular bed: role of rho-kinase. Nephrol Dial Transplant. 2003;18:1764-1769.
22. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol. 2000;522(pt 2):177-185.
23. Gohla A, Schultz G, Offermanns S. Role for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction. Circ Res. 2000;87:221-227.
24. Kimura K, Ito M, Amano M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science. 1996;273:245-248.
25. Lee DL, Webb RC, Jin L. Hypertension and RhoA/Rho-kinase signaling in the vasculature: highlights from the recent literature. Hypertension. 2004;44:796-799.
26. Bauer J, Parekh N. Variations in cell signaling pathways for different vasoconstrictor agonists in renal circulation of the rat. Kidney Int. 2003;63:2178-2186.
27. Mukai Y, Shimokawa H, Matoba T, et al. Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J. 2001;15:1062-1064.
28. Jackson EK, Anderson B, Seasholtz T, et al. Enhanced activation of RhoA by angiotensin II in SHR preglomerular microvascular smooth muscle cells. J Cardiovasc Pharmacol. 2005;45:283-285.
29. Chrissobolis S, Budzyn K, Marley PD, et al. Evidence that estrogen suppresses rho-kinase function in the cerebral circulation in vivo. Stroke. 2004;35:2200-2205.
30. Martin D, Biltoft S, Redetzke R, et al. Castration reduces blood pressure and autonomic venous tone in spontaneously hypertensive rats. J Hypertens. 2005;23:2229-2236.
31. Gao L, Zhu C, Jackson E. Alpha 2 adrenoreceptors potentiate angiotensin II and vasopressin induced renal vasoconstriction in spontaneously hypertensive rats. J Pharmacol Exp Ther. 2003;305:581-586.
32. Nakamura A, Hayashi K, Ozawa Y, et al. Vessel- and vasoconstrictor- dependent role of rho/rho-kinase in renal microvascular tone. J Vasc Res. 2003;40:244-251.
33. Chen YF, Meng QC. Sexual dimorphism of blood pressure in spontaneously hypertensive rats is androgen dependent. Life Sci. 1991;48:85-96.
34. Rowland NE, Fregly MJ. Role of gonadal hormones in hypertension in the DAHL salt sensitive rat. Clin Exp Hypertens A. 1992;14:367-375.
35. Malyusz M, Ehrens HJ, Wrigge P. Effect of castration on the experimental renal hypertension of the rat: blood pressure, nephrosclerosis, long chain fatty acids, and N-acetylation of PAH in the kidney. Nephron. 1985;40:96-99.
36. Song D, Arikawa E, Galipeau D, et al. Androgens are necessary for the development of fructose-induced hypertension. Hypertension. 2004;43:667-672.
37. Chen YF, Meng QC. Sexual dimorphism of blood pressure in spontaneously hypertensive rats is androgen dependent. Life Sci. 1991;48:85-96.
38. Jenkins C, Salisbury R, Ely D. Castration lowers and testosterone restores blood pressure in several rat strains on high sodium diet. Clin Exp Hypertens. 1994;16:611-625.
39. Reckelhoff JF, Zhang H, Srivastava K. Gender differences in the development of hypertension in spontaneously hypertensive rats: role of the renin angiotensin system. Hypertension. 2000;35:480-483.
40. Doggrell SA, Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res. 1998;39:89-105.
41. Chou TM, Sudhir K, Hutchison SJ, et al. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation. 1996;94:2614-2619.
42. Ding AQ, Stallone JN. Testosterone induced relaxation of rat aorta is androgen structure specific and involves K channel activation. J Appl Physiol. 2001;91:2742-2750.
43. Honda H, Unemoto T, Kogo H. Different mechanisms for testosterone induced relaxation of aorta between normotensive and spontaneously hypertensive rats. Hypertension. 1999;34:1232-1236.
44. Tepareenan P, Kendall DA, Randall MD. Mechanisms of vasorelaxation to testosterone in the rat aorta. Eur J Pharmacol. 2003;465:125-132.
45. Wingard C, Johnson J, Holmes A, et al. Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction. Am J Physiol. 2003;284:R1572-R1579.
46. Schror K, Morinelli TA, Masuda A, et al. Testosterone treatment enhances thromboxane A2 mimetic induced coronary artery vasoconstriction in guinea pigs. Eur J Clin Invest. 1994;24(Suppl 1):50-52.
47. Gonzales RJ, Krause DN, Duckles SP. Testosterone suppresses endothelium-dependent dilation of rat middle cerebral arteries. Am J Physiol Heart Circ Physiol. 2004;286:H552-560.
48. Tatchum-Talom R, Martel C, Marette A. Effects of ethinyl estradiol, estradiol, and testosterone on hindlimb endothelial function in vivo. J Cardiovasc Pharmacol. 2002;39:496-502.
49. Blanco-Rivero J, Balfagon G, Ferrer M. Orchidectomy modulates alpha 2 adrenoreceptor reactivity in rat mesenteric artery through increased thromboxane production. J Vasc Res. 2006;43:101-108.
50. Laszlo F, Varga C, Papp A, et al. Difference between male and female rats in vasopressor response to arginine vasopressin. Acta Physiol Hung. 1993;81:137-145.
51. Wangensteen R, Moreno J, Sainz J, et al. Gender difference in the role of endothelium derived relaxing factors modulating renal vascular reactivity. Eur J Pharmacol. 2004;486:281-288.
52. Matsumoto Y, Tanaka K, Harimaya K, et al. Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells. Jpn J Cancer Res. 2001;92:429-438.
53. Moriki N, Ito M, Seko T, et al. RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Hypertens Res. 2004;27:263-270.
54. Uehata M, Ishizaki T, Satoh H, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997;389:990-994.
55. Masumoto A, Hirooka Y, Shimokawa H, et al. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension. 2001;38:1307-1310.
56. Hirooka Y, Shimokawa H. Therapeutic potential of Rho-kinase inhibitors in cardiovascular diseases. Am J Cardiovasc Drugs. 2005;5:31-39.
57. Ratz PH, Berg KM, Urban NH, et al. Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus. Am J Physiol Cell Physiol. 2005;288:C769-783.
58. Kumai T, Tanaka M, Watanabe M, et al. Influence of androgen on tyrosine hydroxylase mRNA in adrenal medulla of spontaneously hypertensive rats. Hypertension. 1995;26:208-212.
59. Davies SP, Reddy H, Cavano M, et al. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000;351:95-105.